FLGT Stock Analysis: Buy, Sell, or Hold?
FLGT - Fulgent Genetics, Inc. Common Stock
$18.09
-0.26 (-1.42%)
▼
5d:
-2.22%
30d:
+15.22%
90d:
+17.24%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jul 31, 2026
Get Alerted When FLGT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FLGT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: FLGT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: FLGT is currently trading at $18.09, which is considered fair relative to its 30-day fair value range of $16.32 to $18.74.
Technical Outlook: Technically, FLGT is in a downtrend. The price is currently testing key support at $17.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FLGT is in a downtrend. The price is currently testing key support at $17.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$16.32 -
$18.74
Company Quality Score
55/100
(HOLD)
Options IV Signal
21th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 21th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($18.50)
Trading Range Analysis
30-Day Trading Range
$16.32 -
$18.74
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$1.28
(7.1%)
Support & Resistance Levels
Support Level
$17.62
Resistance Level
$19.93
Current Trend
Downtrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.01
Wall Street Target
$18.50
(+0.8%)
Revenue Growth (YoY)
-3.2%
Earnings Growth (YoY)
-98.6%
Profit Margin
-23.0%
Share & Embed Analysis
Last updated: June 16, 2026 12:16 PM ET
Data refreshes hourly during market hours. Next update: 1:16 PM
Data refreshes hourly during market hours. Next update: 1:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FLGT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 63 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$141 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
Advanced FLGT Option Strategies
Professional options setups generated by AI based on today's FLGT price and gamma walls.
